Effect of lung cancer surgery on quality of life.
BACKGROUND
Health related quality of life (HRQOL) after surgery is important, although very limited data are available on the QOL after lung cancer surgery.


METHODS
The effect of surgery on HRQOL was assessed in a prospective study of 110 patients undergoing potentially curative lung cancer surgery at Papworth Hospital, 30% of whom had borderline lung function as judged by forced expiratory volume in 1 second. All patients completed the EORTC QLQ-C30 and LC13 lung cancer module before surgery and again at 1, 3 and 6 months postoperatively.


RESULTS
On average, patients had high levels of functioning and low levels of symptoms. Global QOL had deteriorated significantly 1 month after surgery (p = 0.001) but had returned to preoperative levels by 3 months (p = 0.93). Symptoms had worsened significantly at 1 month after surgery but had returned to baseline levels by 6 months. Low values on the preoperative HRQOL scales were not significantly associated with poor surgical outcome. However, patients with low preoperative HRQOL functioning scales and high preoperative symptom scores were more likely to have poor postoperative (6 months) QOL. The only lung function measurement to show a marginally statistically significant association with quality of life at 6 months after surgery was percentage predicted carbon monoxide transfer factor (Tlco).


CONCLUSIONS
Although surgery had short term negative effects on quality of life, by 6 months HRQOL had returned to preoperative values. Patients with low HRQOL functioning scales, high preoperative symptom scores, and preoperative percentage predicted Tlco may be associated with worse postoperative HRQOL.
Win
T
T
Thoracic Oncology Unit, Papworth Hospital, Papworth Everard, Cambridge CB3 8RE, UK. thida.win@papworth.nhs.uk.
Sharples
L
L
Wells
F C
FC
Ritchie
A J
AJ
Munday
H
H
Laroche
C M
CM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D015331:Cohort Studies; D005260:Female; D006304:Health Status; D006801:Humans; D008175:Lung Neoplasms / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D011788:Quality of Life
Chest. 2000 Jun;117(6):1531-2
10858375
Clin Chest Med. 2000 Mar;21(1):107-20, ix
10763093
Lung Cancer. 2001 Feb-Mar;31(2-3):233-40
11165402
Ann Oncol. 2001;12 Suppl 3:S21-5
11804379
J Clin Oncol. 2002 Jul 1;20(13):2920-9
12089220
Chest. 2002 Jul;122(1):21-30
12114334
Qual Life Res. 2003 Mar;12(2):157-66
12639062
Ann Thorac Surg. 2003 Dec;76(6):1821-7
14667591
BMJ. 2004 Oct 30;329(7473):1008
15385408
Thorax. 1973 Sep;28(5):588-91
4784380
Br Heart J. 1990 Nov;64(5):313-6
2245110
Thorax. 1991 Sep;46(9):671-5
1948799
Thorax. 1992 Dec;47(12):1019-24
1494764
Chest. 1993 Jul;104(1):155-9
8325061
Chest. 1994 Jul;106(1):324-5
8020311
J Clin Epidemiol. 1994 Dec;47(12):1443-9
7730853
Curr Opin Oncol. 1995 Mar;7(2):138-43
7756378
Ann Thorac Surg. 1995 Nov;60(5):1522-5
8526679
Eur J Cardiothorac Surg. 1996;10(4):233-7
8740057
J Gen Intern Med. 1997 Nov;12(11):686-97
9383137
Chest. 1998 Feb;113(2):467-81
9498968
Health Qual Life Outcomes. 2003;1:19
12846929
Ann Thorac Surg. 1999 Oct;68(4):1314-20
10543499
Chest. 2000 Jun;117(6):1551-9
10858382